BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5
85 results:

  • 1. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
    Urganci N; Kepil N; Ergun S; Bakkaloglu OK
    J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of Glycated Hemoglobin With a Risk of pancreatic cancer in High-Risk Individuals Based on Genetic and Family History.
    Wu BU; Chen Q; Moon BH; Lustigova E; Nielsen EG; Alvarado M; Ahmed SA
    Clin Transl Gastroenterol; 2024 Jan; 15(1):e00650. PubMed ID: 37800692
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing pancreatic cancer Surveillance.
    Katona BW; Klute K; Brand RE; Everett JN; Farrell JJ; Hawthorne K; Kaul V; Kupfer SS; Paiella S; Simeone DM; Sussman DA; Zogopoulos G; Lucas AL; Kastrinos F;
    Cancer Prev Res (Phila); 2023 Jun; 16(6):343-352. PubMed ID: 37259800
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk of Syndrome-Associated cancers Among First-Degree Relatives of Patients With pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
    Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
    JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Characterization and digital spatial deconvolution of the immune microenvironment of intraductal oncocytic papillary neoplasms (IOPN) of the pancreas.
    Pea A; Paolino G; Martelli F; Bariani E; Piccoli P; Sereni E; Salvia R; Lawlor RT; Cheng L; Chang D; Scarpa A; Luchini C
    Virchows Arch; 2023 Aug; 483(2):157-165. PubMed ID: 37086293
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluating colonoscopy screening intervals in patients with Lynch syndrome from a large Canadian registry.
    Aronson M; Gryfe R; Choi YH; Semotiuk K; Holter S; Ward T; Gallinger S; Cohen Z; Briollais L
    J Natl Cancer Inst; 2023 Jul; 115(7):778-787. PubMed ID: 36964717
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome.
    Cerrato C; Pandolfo SD; Autorino R; Panunzio A; Tafuri A; Porcaro AB; Veccia A; De Marco V; Cerruto MA; Antonelli A; Derweesh IH; Maresma MCM
    World J Urol; 2023 Jul; 41(7):1741-1749. PubMed ID: 36964236
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study.
    Fujitani H; Eguchi H; Kochi Y; Arai T; Muramatsu M; Okazaki Y
    Eur J Cancer Prev; 2023 May; 32(3):286-297. PubMed ID: 36896836
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of
    Peng SH; Chen BB; Kuo TC; Lee JC; Yang SH
    Front Immunol; 2022; 13():1077840. PubMed ID: 36582237
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Significance of the Multi-gene Panel myRisk in Japan.
    Hayashi S; Kubo M; Matsuzaki S; Kai M; Morisaki T; Yamada M; Kaneshiro K; Takao Y; Shimazaki A; Nagayoshi K; Mizuuchi Y; Nakamura M
    Anticancer Res; 2022 Aug; 42(8):4097-4102. PubMed ID: 35896222
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.
    Bennett C; Suguitan M; Abad J; Chawla A
    Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
    Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
    Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications.
    Ban X; Mo S; Lu Z; Jia C; Shao H; Chang X; Mao X; Zhang Y; Pang J; Zhang Y; Yu S; Chen J
    Endocrine; 2022 Sep; 77(3):538-545. PubMed ID: 35708896
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and Prognosis.
    Gisder DM; Overheu O; Keller J; Nöpel-Dünnebacke S; Uhl W; Reinacher-Schick A; Tannapfel A; Tischoff I
    Pathobiology; 2023; 90(2):71-80. PubMed ID: 35691289
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts.
    Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J
    Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling.
    Chen T; Jinlin D; Wang F; Yuan Z; Xue J; Lu T; Huang W; Liu Y; Zhang Y
    Cancer Lett; 2022 Jul; 538():215692. PubMed ID: 35487311
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A morphological and immunohistochemical study of the endoscopic ultrasound-fine-needle biopsy samples from solid pancreatic masses: a single center study.
    Constantinescu A; Ilie-Stan CM; Şandru V; Ungureanu BS; Gheonea DI; Ciurea T; Plotogea OM; Pavel C; Enache V; Munteanu MA; Constantinescu G
    Rom J Morphol Embryol; 2021; 62(3):723-731. PubMed ID: 35263400
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular Features and Clinical Management of Hereditary pancreatic cancer Syndromes and Familial pancreatic cancer.
    Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.